Press releases

* (R) = Regulatory press releases

30 Dec, 2020

(R) New number of shares and votes in Cantargia
21 Dec, 2020

(R) Changes to Cantargia’s nomination committee
16 Dec, 2020

(R) Cantargia has completed a directed share issue of approximately SEK 564 million
15 Dec, 2020

(R) Cantargia announces intention of a directed share issue
26 Nov, 2020

BioInvent and Cantargia sign manufacturing agreement for monoclonal antibody CAN10
12 Nov, 2020

(R) Cantargia publishes interim report for third quarter 2020
20 Oct, 2020

(R) Nomination Committee appointed ahead of 2021 Annual General Meeting
13 Oct, 2020

(R) Extraordinary general meeting in Cantargia AB (publ)
08 Oct, 2020

(R) Cantargia completes recruitment and reports positive interim update in CAN04 pancreatic cancer combination therapy
02 Oct, 2020

(R) Cantargia reports first patient treated with CAN04 in a US phase I study investigating combination with pembrolizumab
Older press releases >>

In media

CEO interview, direct share issue, Redeye (In Swedish) - 2020-12-16

Redeye

CEO interview, direct share issue, Di TV (In Swedish) - 2020-12-16

Di TV

CEO interview, EFN (In Swedish) - 2020-10-16

EFN

CEO interview, Penser Bank Cancer Research Day (In Swedish) - 2020-10-07

Penser Bank

Article about Cantargias antibody based cancer treatment with multiple functions 2019-10-31

Affärstidningen Näringsliv

Presentation at ASCO 2019, follow up articles and interviews - 2019-07-02

ASCO

Cantargia interview at EFN after ASCO - 2019-06-17

EFN

CEO interview, Edison, London - 2019-02-26

Edison TV

CEO interview, EFN, Lund (In Swedish) - 2018-11-22

EFN

Interview around CAN04 clinical results, Redeye, Stockholm (In Swedish) - 2018-10-23

Redeye

Listing ceremony for Cantargia on Nasdaq Stockholm Main Market - 2018-09-25

Nasdaq

CEO interview in connection with listing Nasdaq Stockholm (Small Cap), EFN, Stockholm (In Swedish) - 2018-09-25

EFN

CEO interview in connection with listing Nasdaq Stockholm (Small Cap), Ditv, Stockholm (In Swedish) - 2018-09-25

Di

CEO interview, Redeye, Stockholm (In Swedish) 2018-09-06

Redeye

CEO interview, BioStock Live, Stockholm (In Swedish) -2018-08-29

Direkt Studios

Småbolagspanelen: Om framtidens cancerbehandlingar, Småbolagsdagen, Stockholm (in Swedish) 2018-06-11

Aktiespararna

CEO interview BioStock Live, Stockholm (In Swedish) -2018-03-20

Direkt Studios

CEO-interview 2017-12-12

Aktiespararna

Interview with Cantargia's CEO Göran Forsberg after the presentation at BioStock Live i Stockholm - 2017-12-04

Direkt Studios

CEO-interview - 2017-11-29

Finwire.tv

Video, interview Göran Forsberg, President Cantargia, Sedermera-dagen, Lund - 2016-03-16

Finwire.tv

CONTACT US
Cantargia AB
Scheelevägen 27
SE-223 63 Lund, Sweden

E-mail: info@cantargia.com
Switch board: +46(0)46 2756260

Privacy Policy

Subscribe to our press releases

© Copyright 2021 · Cantargia AB